Showing results (2041-2050 of 9,904) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|October 30, 2019
Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplantAnne L Ryan, Ushma D Wadia, Peter Jacoby, et al.Bone Marrow Transplantation|November 13, 2020
Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from PakistanMaryam Khan, Raheel Iftikhar, Tariq Ghafoor, et al.Bone Marrow Transplantation|November 14, 2020
Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the questionJavier Marco-Ayala, Inés Gómez-Seguí, Guillermo Sanz, et al.Bone Marrow Transplantation|December 1, 2020
Incorporation of posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants: a retrospective, single institution studyDennis L Cooper, Jacqueline Manago, Vimal Patel, et al.Bone Marrow Transplantation|November 25, 2020
Secondary oral cancer following hematopoietic cell transplantationStella Santarone, Annalisa Natale, Stefano Angelini, et al.Bone Marrow Transplantation|February 21, 2018
The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemiaKiyosumi Ochi, Shigeo Fuji, Kuniko Takano, et al.Bone Marrow Transplantation|February 11, 2018
Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantationLucia E Duinhouwer, Nick Beije, Bronno van der Holt, et al.Bone Marrow Transplantation|January 24, 2020
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panelFrancesca Bonifazi, Marie-Thérèse Rubio, Andrea Bacigalupo, et al.Bone Marrow Transplantation|January 30, 2020
Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantationDeena R Levine, Kelsey Van Noy, Aimee C Talleur, et al.Bone Marrow Transplantation|January 30, 2020
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survivalShawn Kothari, Andrew S Artz, Sang Mee Lee, et al.Pageof 991